Codex DNA Inc. (NASDAQ: DNAY) kicked off on June 27, 2022, at the price of $2.11, up 15.02% from the previous trading day. During the day, the shares moved up to $2.55 and dropped to $2.10 before settling in for the closing price of $2.13. Over the past 52 weeks, DNAY has traded in a range of $1.87-$25.70.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
While this was happening, its average annual earnings per share was recorded -247.00%. With a float of $18.51 million, this company’s outstanding shares have now reached $29.33 million.
The firm has a total of 264 workers. Let’s measure their productivity. In terms of profitability, gross margin is +24.68, operating margin of -320.33, and the pretax margin is -352.66.
Codex DNA Inc. (DNAY) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Codex DNA Inc. is 0.40%, while institutional ownership is 59.60%.
Codex DNA Inc. (DNAY) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$0.45 earnings per share (EPS), lower than consensus estimate (set at -$0.43) by -$0.02. This company achieved a net margin of -352.78 while generating a return on equity of -119.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -247.00% per share during the next fiscal year.
Codex DNA Inc. (NASDAQ: DNAY) Trading Performance Indicators
Take a look at Codex DNA Inc.’s (DNAY) current performance indicators. Last quarter, stock had a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.52, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.66 in one year’s time.
Technical Analysis of Codex DNA Inc. (DNAY)
Analysing the last 5-days average volume posted by the [Codex DNA Inc., DNAY], we can find that recorded value of 3.67 million was better than the volume posted last year of 0.44 million. As of the previous 9 days, the stock’s Stochastic %D was 25.06%. Additionally, its Average True Range was 0.40.
During the past 100 days, Codex DNA Inc.’s (DNAY) raw stochastic average was set at 6.34%, which indicates a significant decrease from 29.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.55% in the past 14 days, which was lower than the 132.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.68, while its 200-day Moving Average is $7.41. Now, the first resistance to watch is $2.63. This is followed by the second major resistance level at $2.82. The third major resistance level sits at $3.08. If the price goes on to break the first support level at $2.18, it is likely to go to the next support level at $1.92. Should the price break the second support level, the third support level stands at $1.73.
Codex DNA Inc. (NASDAQ: DNAY) Key Stats
The company with the Market Capitalisation of 67.64 million has total of 29,398K Shares Outstanding. Its annual sales at the moment are 11,040 K in contrast with the sum of -38,960 K annual income. Company’s last quarter sales were recorded 5,640 K and last quarter income was -13,190 K.
